Researchers have discovered that cancer spread isn’t random—it follows a kind of biological “program.” By studying colon tumor cells, they identified gene patterns that signal whether a cancer is ...

Novartis AG agreed to buy an experimental breast cancer drug from Synnovation Therapeutics for as much as $3 billion to bolster its oncology pipeline.

WASHINGTON, D.C. — The House Agriculture Committee advanced a new five-year farm bill on Thursday, sending it to the House floor for a full vote. The farm bill was traditionally a bipartisan effort ...

Equity-Insider.com News Commentary -- Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced four strategic additions to its executive leadership team: Jeff ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research ...

IPN01203 data to be presented at coveted New Drugs on the Horizon program session, demonstrating early potential of this novel T cell activator to transform care in solid tumors ITGA2 revealed as ...

Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that nine oral and poster ...

Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from Cancer Research UK, between 2022 and 2024, around 247 people per 100,000 ...

Over the last two years, research has improved the understanding and treatment of disease. Using tools such as gene editing, ...

This past week, LCGC International highlighted recent milestones and research advancements in the field of chromatography and analytical science. Key announcements from Pittcon 20 ...